Anthony E. Naassan

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Free Fatty Acid–Induced Reduction in Glucose-Stimulated Insulin Secretion

Andrei I. Oprescu, George Bikopoulos, Anthony E. Naassan et al. · Diabetes · 2007 · 189 citations · Full text

Life Sciences, Biochemistry, Endocrinology +17

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

Susceptibility to Fatty Acid-Induced β-Cell Dysfunction Is Enhanced in Prediabetic Diabetes-Prone BioBreeding Rats: A Potential Link Between β-Cell Lipotoxicity and Islet Inflammation

Christine Tang, Anthony E. Naassan, Astrid Chamson-Reig et al. · Endocrinology · 2012 · 38 citations · Full text

Medicine, Biochemistry, Endocrinology +16

In vivo effects of polyunsaturated, monounsaturated, and saturated fatty acids on hepatic and peripheral insulin sensitivity

Sandra Pereira, Danna M. Breen, Anthony E. Naassan et al. · Metabolism · 2014 · 31 citations

Life Sciences, Endocrinology, Nutritional Sciences +16